The gastrointestinal cancer-associated antigen (GICA) is recognised by a monoclonal antibody in both serum and tissues ofpatients with neoplasm of the GI tract. This study compared the serum and saliva values of carcinoembryonic antigen (CEA) and GICA in 19 healthy subjects, 43 patients with benign oral cavity lesions and 26 with histologically confirmed squamous-cell carcinomas. Serum CEA levels were much the same in all three groups, whereas salivary values were significantly higher (p < 0.001) in both patient groups than in the controls. Serum GICA gave the opposite result: lower in carcinoma than in controls (p < 0.001) and benign lesions (N.S.), while salivary GICA was significantly lower in carcinoma than in both the other two groups (p < 0.001). The meaning of this difference between the values for the two antigens is discussed.
KoprowskiH., HerlynM., SteplewskiZ., SearsH.F.Specific antigen in serum of patients with colon carcinoma.Science1981; 212: 53–5.
2.
HerlynM., SteplewskiZ., HerlynD., KoprowskiH.Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proc Natl Acad Sci USA1979; 76: 1438–42.
3.
MagnaniJ.L., NilssonB., BrockhausM.. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialy-lated lacto-N-fucopentaose II.J Biol Chem1982; 257: 14365–9.
4.
MagnaniJ.L., BrockhausM., SmithD.F.. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma.Science1981; 212: 55–6.
5.
HanssonG.C., KarlssonK.A., LarsonG.. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens.J Biol Chem,1983; 258: 4091–7.
6.
KoprowskiH., BrockhausM., BlaszczykM.. Lewis blood - type may affect the incidence of gastrointestinal cancer.Lancet1982; 12: 1332–3.
RauxH., LabbeF., FondanecheM.C.. A study of gastrointestinal cancer-associated antigen (GICA) in human fetal organs.Int J Cancer1983; 32: 315–9.
9.
MagnaniJ.L., SteplewskiZ., KoprowskiH., GinsburgV.Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.Cancer Res1983; 43: 5489–92.
10.
OldingL.B., ThurinJ., SvalanderC., KoprowskiH.Expression of gastrointestinal carcinoma associated antigen (GICA) detected in human fetal tissues by monoclonal antibody NS-19-9.Int J Cancer1984; 34: 187–92.
11.
CharpinC., BhanA.K., ZurawskiV.R.Jr., ScullyR.E.Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9). Localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.Int J Gyn-Path1982; 1: 231–45.
12.
OldingL.B., AhrenC., ThurinJ.. Gastrointestinal carcinoma-associated antigen detected by a monoclonal antibody in dysplasia and adenocarcinoma associated with chronic ulcerative colitis.Int J Cancer1985; 36: 131–6.
13.
SteplewskiZ., ChangT.H., HerlynM., KoprowskiH.Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.Cancer Res1981; 41: 2723–7.
14.
RittsR.E.Jr., Del VillanoB.C., GoV.L.W.. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.Int J Cancer1984; 33: 339–45.
15.
HerlynM., SearsH.F., SteplewskiZ., KoprowskiH.Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma.J Clin Immunol1982; 2: 135–40.
16.
KlapdorR., LemannU., BahloM.. CA 19-9 in der Diagnostik und Differentialdiagnostik des exkretori-schen Pankreaskarzinoms.Tumordiagnostik & Terapie1983; 5: 27–31.
17.
RuibalA., EncaboG., GefaellR.. Clinical interest of seric CA 19-9 determination in differential diagnosis of patients with peptic ulcers and gastric cancer.Bulletin du cancer1983; 70: 438–40.
18.
JalankoJ., KuuselaP., RobertsP.. Comparison of a new tumour marker, CA 19-9™, with alpha-fetopro-tein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.J Clin Pathol1984; 37: 218–22.
19.
PutzkiH., StudentA., JablonskiM., HeymannH.Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.Cancer1987; 59: 223–6.
20.
RuibalA., EncaboG., MirallesE.M.. CA 19-9 as a tumor marker. Correlation with CEA and TPA. Poster presented at the “International Meeting on Monoclonal Antibodies in Oncology: Clinical Applications”, Nantes (France), June 1984.
21.
ArendsJ.W., VerstijnenC., BosmanF.T.. Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study.Hybridoma1983; 2: 219–29.
22.
ArendsJ.W., WiggersT., VerstijnenC.. Gastrointestinal cancer-associated antigen (GICA) immuno-reactivity in colorectal carcinoma in relation to patient survival.Int J Cancer1984; 34: 193–6.
23.
MartinF., DevantJ.Carcinoembryonic antigen in normal human saliva.J Natl Cancer Inst1973; 50: 1375–8.
24.
SilvermannN.A., AlexanderJ.C.CEA levels in head neck cancer.Cancer1976; 37: 2204–11.
